mRNA Archives · BioBuzz

Loading …

Cartesian Therapeutics Initiates Phase 2 Clinical Trial of First RNA-Engineered Cell Therapy for Frontline Cancer

<img width="300" height="244" alt="" data-src="https://biobuzz.io/wp-content/uploads/2019/11/Cartesian-Therapeutics-300x244.jpeg" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="244" src="https://biobuzz.io/wp-content/uploads/2019/11/Cartesian-Therapeutics-300x244.jpeg" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" />

Published on : February 22, 2021February 22, 2021 Published by : BioBuzz Media

Cartesian Therapeutics Initiates Phase 2 Clinical Trial of First RNA-Engineered Cell Therapy for Frontline Cancer Descartes-11 specifically designed to integrate into standard treatment regimen for newly diagnosed multiple myeloma without [….]

How mRNA-based Vaccines Have Changed the Vaccine Game

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2021/01/mRNA-vaccines-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2021/01/mRNA-vaccines-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2021/01/mRNA-vaccines-75x75.png 75w" data-src="https://biobuzz.io/wp-content/uploads/2021/01/mRNA-vaccines-300x300.png" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2021/01/mRNA-vaccines-300x300.png" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2021/01/mRNA-vaccines-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2021/01/mRNA-vaccines-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2021/01/mRNA-vaccines-75x75.png 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : January 5, 2021January 5, 2021 Published by : Amanda Donohue

With the unprecedented speed of vaccine development amid the COVID-19 pandemic, questions have emerged regarding the future of vaccinology beyond the coronavirus. In a panel on vaccinology in the 21st century hosted by Noble Life Sciences, scientists discussed the vaccine platforms available to us now, the significance of mRNA vaccines and the emergence of new combination vaccines.